Oslo University Hospital

Oslo University Hospital (OUH) is a highly specialized hospital in charge of extensive regional and local hospital assignments, and is accredited as a Comprehensive Cancer Center (CCC). As Scandinavia’s largest hospital, we carry out more than 1.2 million patient treatments each year. The hospital has a responsibility for a number of national and multi-regional assignments, and has several national centers of competence. OUH is responsible for approximately 50 percent of all medical and health care research conducted at Norwegian hospitals, and is a significant role player within the education of a large variety of health care personnel. The hospital hosts one of the largest radiotherapy centers world-wide, with about 6000 new patients receiving state-of-the-art radiotherapy each year. The center is located at the Radium Hospital in close vicinity to the Institute for Cancer Research. A Proton Therapy center is under construction at the same location. The Proton Therapy center will open in 2024-2025 and includes a cyclotron, 2 treatment rooms for cancer patients and a facility for preclinical research. We plan to include about 75% of all patients treated at the proton center in clinical studies. The preclinical proton facility will consist of a treatment room with gantry, a room for stalling and work with small animals, a preclinical MR-scanner and laboratory for cell work and will offer a unique setting for proton therapy research.

Institute for Cancer Research
The Institute for Cancer Research (ICR) organized as a part of the Division of Cancer Medicine at OUH, conducts cutting edge cancer research ranging from basic cancer biology to translational and clinical research. It is the leading cancer research institute in Norway and has a strong international standing. ICR is organized in 6 research departments, currently with altogether 25 research groups, approx. 390 employees and an annual output of approx. 230 peer reviewed publications. Particularly strong research areas are molecular genetics, cell biology, cancer progression and metastasis biology, biomarker discovery and development, radiation biology, tumour immunology/immunotherapy and systems biology. The groups conduct particularly strong translational research within breast cancer, colorectal cancer, lung cancer, lymphomas, sarcomas, melanoma, gynaecologic cancers and prostate cancer. ICR also hosts a department for core facilities including NGS/genomics platforms, bioinformatics, flow- and mass cytometry, pre-clinical imaging scanner (incl. animal MRI) and X-ray machine, and electron-, confocal- and high-resolution microscopy. In collaboration with The University of Oslo, ICR is in the leadership of a Center of Excellence (CanCell), a K.G. Jebsen Center for B cell malignancies, a Centre for Advanced Cell Therapy (ACT) and a new Norwegian Centre for Clinical Cancer Research (MATRIX), as well as other large nation-wide collaborative projects and EU funded projects. For further information see institute; ous-research.

 

Oslo University Hospital is a workplace with great diversity. We believe that this is absolutely crucial to solving the tasks required of us. We therefore want this diversity to be reflected among the applicants for our positions and encourage everyone to apply regardless of who you are and what background you have.

Kvalifikasjoner:

• Master's degree in molecular cell biology, pharmacy or biomedical sciences
• Approved course of laboratory Animal Sciences for scientists. FELASA Cat. C
  
• Experience with automatized liquid chromatography systems
  
• Experience with standard in vitro methods in cancer research
  
• Experience with photomedicine
  
• Experience with laboratory mice
  
• Fluent in oral and written English (Norwegian is an advantage).
  
• Digital competence is an advantage.

Personlige egenskaper:

• Strong teamwork skills
• Analytical and Critical Thinking
• Ability to work independently and take initiatives
• Entrepreneurial mind-set
  

Vi tilbyr:

• Exciting and stimulating tasks in a strong international academic environment
  an open and inclusive work environment with dedicated colleagues
• The position is included in the Norwegian Health Assurance and Retirement Pension Schemes, and the salary will be within the official range at OUH for PhD candidates.
• An enthusiastic work environment with broad expertise and high professional level
• Access to high quality instrumentation and services from the Core Facility Department and other in-house instrumentation, such as a preclinical research facility, MRI and X-ray sources for in vitro and in vivo studies, hypoxia-chamber, IVIS, Seahorse (see also corefacilities).
•  For additional information please contact Project leader dr. Anette Weyergang, Mobile +47- 40204557, postdoc dr. Sergio Miguel Castaneda Zegarra, Mobile + 47 92336484 or senior scientist, prof. em. Kristian Berg, Mobile +47 40873549.

The Application must include

• CV and certificates
• One page summary describing how you meet the required selection criteria listed above
• Transcripts and diplomas for bachelor's and master's degrees. 
• Diploma confirming approved course of laboratory Animal Sciences for scientist FELASA Cat. C
• Recommendation letters may be included, but not a requirement
  
• Name and contact information of three referee